Glioblastoma Clinical Trials in Long Beach, CA

Glioblastoma Clinical Trials in Long Beach, CA

View the best 10 glioblastoma medical studies in Long Beach, California. Access promising new therapies by applying to a Long Beach-based Glioblastoma clinical trial.

Top rated glioblastoma clinical trials in Long Beach, California

Here are the top 10 medical studies for glioblastoma in Long Beach, California

Image of Children's Hospital of Alabama in Birmingham, United States.

Erdafitinib

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 2
This trial uses erdafitinib to treat patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders that have spread and come back or don't respond to treatment with FGFR mutations.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Ipilimumab +2 More

Checkpoint Inhibitor

Recruiting1 awardPhase 2 & 3
This trial is testing whether adding immunotherapy to radiation therapy can help people with newly diagnosed glioblastoma that has an unmethylated MGMT.
Image of 1004 in Denver, United States.

BDTX-1535

Small Molecule Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug for people with glioblastoma or non-small cell lung cancer who have disease progression following standard of care.
Image of Grandview Cancer Center in Birmingham, United States.

OptuneĀ®

Device

Recruiting1 award12 criteria
This trial is testing a new treatment for brain cancer that combines Optune with radiation and chemotherapy. The goal is to see if this new combination is more effective and has fewer side effects than current treatments.
Image of UC Irvine Health Cancer Center-Newport in Costa Mesa, United States.

Olaparib

PARP Inhibitor

Recruiting1 awardPhase 2
This trial will study how well olaparib works in treating patients with certain types of cancer that have spread and usually cannot be controlled with treatment. Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Image of START Midwest, LLC in Grand Rapids, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial is testing a new cancer drug, NGM707, as a possible treatment for advanced solid tumors. It will be tested alone and in combination with another cancer drug, pembrolizumab.
Image of Saint Joseph's Hospital and Medical Center in Phoenix, United States.

Bevacizumab

Monoclonal Antibodies

Recruiting1 award
This trial uses DSC-MRI to measure rCBV to determine response to bevacizumab in patients with recurrent glioblastoma. DSC-MRI may help to evaluate changes in cancer blood vessels.
Image of Valkyrie Clinical Trials in Beverly Hills, United States.

Pemigatinib

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 2
This trial is testing a drug called pemigatinib for people with recurrent glioblastoma or other primary brain tumors. Pemigatinib will be given daily on a 2-week on, 1-week off schedule. The trial will enroll about 82 people in each of 3 cohorts.
Image of University of California, Los Angeles in Los Angeles, United States.

Temozolomide +1 More

Anti-cancer agent

Recruiting1 awardPhase 1 & 2
This trial will study the safety and effectiveness of a new drug, AQ4N, for treating Huntington's disease.
Image of Banner MD Anderson in Gilbert, United States.

APL-101

Small Molecule Inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug to see if it is safe and effective for people with different types of cancer.

Popular filter options for glioblastoma long-beach trials

Clinical Trials With No Placebo

View 61 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' ā€” so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back ā€” in general, verified trials respond to patients within a few days.